Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Argyriou

Showing results (1-10 of 186) with videos related to

Pageof 19
Sort By:
Molecular Medicine (Cambridge, Mass.)|July 14, 2009
Molecularly targeted therapies for dysimmune neuropathiesAndreas A Argyriou
Toxics|October 24, 2017
Updates on Oxaliplatin-Induced Peripheral Neurotoxicity (OXAIPN)Andreas A Argyriou
Acta Neurologica Scandinavica|March 14, 2008
Neuromyelitis optica: a distinct demyelinating disease of the central nervous systemA A Argyriou, N Makris
Acta Neurologica Scandinavica|October 12, 2007
Painful limbs/moving extremitiesS Papapetropoulos, A A Argyriou
Reproductive Sciences (Thousand Oaks, Calif.)|November 20, 2008
Multiple sclerosis and reproductive risks in womenAndreas A Argyriou, Nicolaos Makris
Molecular Medicine (Cambridge, Mass.)|January 17, 2009
Molecularly targeted therapies for malignant gliomasAndreas A Argyriou, Haralabos P Kalofonos
Brain Research|September 23, 1996
Histaminergic neurons facilitate social memory in ratsH Prast, A Argyriou, A Philippu
European Journal of Pharmacology|July 22, 1998
Melatonin facilitates short-term memoryA Argyriou, H Prast, A Philippu
Molecular Medicine (Cambridge, Mass.)|March 24, 2009
Recent advances relating to the clinical application of naked monoclonal antibodies in solid tumorsAndreas A Argyriou, Haralabos P Kalofonos
Journal of Neurology|April 19, 2005
Factors associated with drug-induced visual hallucinations in Parkinson's diseaseSpiridon Papapetropoulos, Andreas A Argyriou, John Ellul
Pageof 19

Showing results (1-10 of 186) with videos related to

Sort By:
Pageof 19
Molecular Medicine (Cambridge, Mass.)|July 14, 2009
Molecularly targeted therapies for dysimmune neuropathiesAndreas A Argyriou
Toxics|October 24, 2017
Updates on Oxaliplatin-Induced Peripheral Neurotoxicity (OXAIPN)Andreas A Argyriou
Acta Neurologica Scandinavica|March 14, 2008
Neuromyelitis optica: a distinct demyelinating disease of the central nervous systemA A Argyriou, N Makris
Acta Neurologica Scandinavica|October 12, 2007
Painful limbs/moving extremitiesS Papapetropoulos, A A Argyriou
Reproductive Sciences (Thousand Oaks, Calif.)|November 20, 2008
Multiple sclerosis and reproductive risks in womenAndreas A Argyriou, Nicolaos Makris
Molecular Medicine (Cambridge, Mass.)|January 17, 2009
Molecularly targeted therapies for malignant gliomasAndreas A Argyriou, Haralabos P Kalofonos
Brain Research|September 23, 1996
Histaminergic neurons facilitate social memory in ratsH Prast, A Argyriou, A Philippu
European Journal of Pharmacology|July 22, 1998
Melatonin facilitates short-term memoryA Argyriou, H Prast, A Philippu
Molecular Medicine (Cambridge, Mass.)|March 24, 2009
Recent advances relating to the clinical application of naked monoclonal antibodies in solid tumorsAndreas A Argyriou, Haralabos P Kalofonos
Journal of Neurology|April 19, 2005
Factors associated with drug-induced visual hallucinations in Parkinson's diseaseSpiridon Papapetropoulos, Andreas A Argyriou, John Ellul
Pageof 19